FDA drug shortages

What FDA drug shortages tracking is

The FDA maintains a public record of drug shortages — situations in which the supply of a drug product does not meet the demand for it. The agency tracks the affected product (by generic and brand name where available), the company reporting the shortage, the status of the shortage, the affected presentation, supporting availability information, and the dates on which the entry was first posted and last updated. This information underpins a great deal of operational planning in the health system: hospital pharmacies, group purchasing organisations, manufacturers and distributors all rely on it to anticipate and manage supply disruptions.

Our shortages section indexes that public data, normalises the product names, companies, statuses and dates into a consistent shape, and presents each entry on a stable URL with a link back to the official FDA source. The aim is the same as elsewhere on the site: to make a public but awkward-to-navigate dataset quick to search, date and cross-reference. We do not reproduce the FDA's clinical or supply commentary, and we add no interpretation of our own beyond deterministic, source-derived descriptions.

Shortage status: current, resolved and beyond

Each shortage record carries a status describing where the shortage sits in its lifecycle. On this site those statuses are normalised into a small, consistent set:

• Current — an active shortage, as recorded by the FDA. These are the entries most relevant to live procurement planning, and they are collected on the current shortages page.
• Resolved — a shortage the FDA has recorded as ended.
• Discontinued — a product the source records as discontinued rather than in active shortage.
• Unknown — used only when the source does not state a status; we never guess one.

In the indexed dataset, statuses currently break down as 238 current, 0 resolved, 12 discontinued and 0 unknown. A status is a regulatory data field, and the live value should always be confirmed against the official FDA source, because shortage situations can change quickly.

Latest shortage records

The most recently updated shortage records in the indexed dataset are listed below, newest first. Each links to its own record page and, from there, to the official FDA shortage source.

Why this site does not suggest substitutes

A drug shortage can have real operational consequences, but deciding how to respond to one is a clinical and professional judgement, not an indexing task. For that reason this site is deliberately limited to reporting the regulatory supply signal: which product, which company, what status, and which dates. It does not suggest alternative products, does not comment on therapeutic equivalence, and does not advise any course of action. Those decisions belong with qualified healthcare professionals working from the authoritative FDA record and the full clinical context.

What each shortage record contains

Each shortage record page presents the same regulatory fields drawn from the FDA's public shortage data. The generic and brand names identify the affected product as the source records it; we show both where they are available and neither when the source does not provide them. The reporting company is the firm associated with the entry. The status places the shortage in its lifecycle. The presentation field describes the affected package or formulation as published, and the availability field reproduces the FDA's supply text as a data point — never reframed as advice. Two dates, the initial posting date and the last-updated date, let you judge how recent the entry is and how long the situation has been tracked.

Showing these fields consistently is what makes the shortage data quick to scan and compare across products and companies. The structure adds organisation, not interpretation: it does not assess clinical impact, does not rank products, and does not imply anything about how a shortage should be managed. Those are professional judgements that belong with the people responsible for supply and care, working from the authoritative FDA record. Each record page links straight back to that official source so the live status can always be confirmed.